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Testosterone promotes apoptotic damage in human renal tubu-
lar cells.
Background. Apoptosis is a mode of cell death that partic-
ipates in the kidney physiologic remodeling processes and is
thought to contribute to cell loss and kidney structural damage
in chronic renal diseases. Gender is one factor which contributes
to accelerated nephron loss, with progression more rapid in
men than in women in diabetic and nondiabetic chronic renal
diseases. Mechanisms by which androgens may cause higher
rate of progression of chronic renal diseases in men are poorly
explored.
Methods. In this study, to investigate the role of androgens
on apoptotic damage and its associated mechanisms, we exam-
ined the effects of testosterone (T) (0.1 nmol/L to 1 lmol/L) on
apoptosis, and apoptosis-related proteins in a proximal human
tubule cell line (HK-2 cells). Additional experiments were per-
formed in primary cultures of proximal tubular epithelial cells
(PTECs). Cells were grown to subconfluence in normal growth
medium, and apoptotic damage was induced by serum depriva-
tion for 24 to 48 hours. Cycloheximide, flutamide (a T-receptor
antagonist), 17-b estradiol, or caspase inhibitors were added
to cultures that were successively processed for terminal de-
oxynucleotidyl transferase-mediated uridine triphosphate nick
end-labeling (TUNEL) analysis, annexin V/propidium iodide
staining, immunofluorescence, or immunoblots to identify ef-
fects and apoptotic pathways that could be modulating cell
survival.
Results. Both morphologic analysis by annexin V/propidium
iodide staining and TUNEL showed that physiologic T levels
(1 to 10 nmol/L) induced a significant increase in apoptosis both
in HK-2 cells and PTECs. In both types of cell lines pretreatment
with the androgen receptor antagonist flutamide prevented
the T-induced apoptosis. T-induced apoptosis was enhanced by
treatment with cycloheximide and prevented by 17b-estradiol.
Fas, Fas ligand (FasL), and Fas-associating death domain
containing protein (FADD) were clearly up-regulated within
48 hours of T treatment in HK-2 cells. Also, T significantly in-
creased the expression of Bax protein (P < 0.01 vs. control) (an
effect which was blocked by flutamide), and decreased the ex-
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pression of Bcl-2. Western blot analysis showed that caspase-3
was activated. Moreover, cleavage into an 85-kD poly(ADP-
ribose) polymerase-1 (PARP-1) terminal breakdown product
was detectable. The changes in cellular morphology induced
by T at 48 hours were no longer observed after the addition
of caspase-8, caspase-9, and caspase-3 inhibitors to the culture
medium.
Conclusion. These results indicate that T increases the per-
missiveness of proximal tubule kidney cells to apoptotic effects
by triggering an apoptotic pathway involving caspase activa-
tion, Fas up-regulation, and FasL expression, thus potentially
interacting with mechanisms of cell loss which have been al-
ready shown to be activated in chronic renal diseases. This is
consistent with a role for T in promoting renal injury in men.
Apoptosis is a mode of cell death that participates in
kidney physiologic remodeling processes [1, 2] and is
thought to contribute to cell loss and kidney structural
damage in chronic renal diseases [1, 3–6]. Gender is one
factor that likely contributes to accelerated nephron loss,
with progression more rapid in men than in women in
diabetic and nondiabetic chronic renal diseases [7]. The
specific mechanisms underlying this clinical finding may
be related to genetically determined differences between
the sexes in renal structure and function and/or to the di-
rect effects of sex hormones on renal tissues [6]. Estrogen
has been shown to stimulate renal nitric oxide genera-
tion and to modulate the synthesis and release of various
growth factors, hormones, and cytokines [7]. Female hor-
mones may also induce protective effects in mesangial
cells, including suppression of collagen gene transcrip-
tion and protection from transforming growth factor b1
(TGF-b1)-induced apoptosis [8]. By contrast, the effects
of androgens on processes contributing to the progression
of chronic renal diseases have been less extensively stud-
ied. Androgens can interact with the renin-angiotensin
system and potentiate the damage induced in the kidney
and extra-renal tissues by hypertension [9]. Androgens
can also increase collagen synthesis by vascular smooth
muscle cells and promote the accumulation of collagen
and elastin in vessels [10]. In addition, androgens can
induce apoptosis in human vascular endothelial cells, and
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in this way may contribute to the increased risk of vascu-
lar events in men [11]. However, the interaction of andro-
gens with cell survival and death is complex and appears
to be variably regulated in various tissues of the body
[12, 13]. Although the clinical significance of cell death
by apoptosis in chronic kidney diseases is yet to be fully
established, several observations indicate that some kid-
ney structures may be particularly involved by apoptotic
processes. In normal rat kidney, proximal tubular epithe-
lium is the main site of Fas and FasL expression, which can
promote apoptosis by caspase activation [14, 15]. More-
over, the Fas/FasL system is up-regulated during renal
injury [1, 15]. In experimental chronic kidney disease, cel-
lular apoptosis outweighs proliferation, thus favoring cell
deletion and progressive tubular atrophy [16]. Finally, in
patients with chronic glomerulonephritis, an increase in
apoptotic tubular cells has been detected [17].
Here, we examine if T induces apoptosis in human kid-
ney proximal tubular cells. We also examine alterations
in the expression and/or activity of a wide variety of
apoptosis-associated proteins after T exposure and in-
vestigate the role of Fas/FasL and caspases in the execu-
tion of cell death. Our results demonstrate that T causes
apoptosis of tubular cells through Fas sensitization and
activation of caspase-dependent apoptotic pathway, thus
potentially interacting with mechanisms of cell loss which
have been already shown to be activated in chronic renal
diseases.
METHODS
Reagents
Media and additives for culture of HK-2 cells, as
well as annexin fluoroscein isothiocyanate (FITC), pro-
pidium iodide, 3,3-diaminobenzidine (DAB), testos-
terone, flutamide, 17b-estradiol, phenazine methosul-
fate, p-iodonitrotetrazolium violet, b-NAD, L-(+)-lactic
acid, cycloheximide, acrylamide, and other reagents
for sodium dodecyl sulphate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) were purchased from Sigma
Chemical Company (St. Louis, MO, USA). Caspase in-
hibitors were purchased from R&D Systems Europe,
Ltd. (Oxon, UK). Coomassie protein assay reagent was
obtained from Pierce (Rockford, IL, USA). Tissue cul-
ture plates and dishes were from Corning (New York,
NY, USA). Antihuman Bcl-2 monoclonal antibody, an-
tihuman Bax polyclonal antobody, antihuman Fas and
FasL antibodies were obtained from Upstate Biotechnol-
ogy (Lake Placid, NY, USA). Antihuman-cleaved poly
(ADP-ribose) polymerase-1 (PARP-1) polyclonal anti-
body was purchased from Alexis Biochemicals (Lausen,
Switzerland). Antihuman FADD (monoclonal antibody)
and antiactive caspase-3 (p17) monoclonal antibody were
purchased from BioVision Research Products (Mountain
View, CA, USA).
The biotin-streptavidin-amplified detection system
was obtained from Biogenex (Biogenex Laboratories,
San Ramon, CA, USA) and Eukitt from O Kindler
GmbH and Co. (Freiburg, Germany). Terminal deoxynu-
cleotidyl transferase (TdT), TdT buffer, and biotyni-
lated dUTP were obtained from Boehringer Mannheim
(Mannheim, Germany). Hybond-c-nitrocellulose mem-
brane, enhanced chemiluminescent reaction ECL, and
Hyperfilm-ECL were obtained from Amersham Pharma-
cia Biotech (Arlington Heights, IL, USA).
Cell culture
HK-2 cells, an immortalized proximal tubular epithe-
lial cell line from normal adult human male kidney,
were obtained from American Tissue Culture Collection
(ATCC, Manassas, VA, USA). Primary human proximal
tubular epithelial cells (PTECs) were cultured according
to the method of Detrisac et al [18]. Portions of renal cor-
tex not involved by disease were obtained from male kid-
neys removed by surgery for renal cell carcinoma. Small
fragments of renal tissue were placed on a matrix of type
I bovine collagen and fetal bovine serum (FBS). Out-
growth of PTECs was confirmed by their morphologic ap-
pearance, enzyme cytochemistry (reactivity for alkaline
phosphatase, gamma-glutamyltranspeptidase, acid phos-
phatase, and leucine aminopeptidase), and immunofluo-
rescence. PTECs were used between the third and fifth
passage. Cells were grown in phenol red-free Dulbecco’s
modified Eagle’s medium (DMEM)/F12 medium sup-
plemented with 5% (v/v) FBS, 100 U/mL penicillin-
streptomycin, 2 mmol L-glutamine, 5 lg/mL insulin,
5 lg/mL transferrin, 5 ng/mL sodium selenite, 5 pg/mL T3,
5 ng/mL hydrocortisone, 5 pg/mL PGE1, and 10 ng/mL
epidermal growth factor. Cells were grown at 37◦C in a
humidified 5% CO2 condition.
Cell treatments
Cells were grown to subconfluence in normal growth
medium, and apoptotic damage was induced by additives
and serum deprivation for 24 to 48 hours in the pres-
ence of T (0.1 nmol/L to 1 lmol/L). Control cells (C)
were not treated with hormone. In order to determine
if T is directly involved in apoptosis, the antiandrogen
flutamide (100 nmol/L) was added 4 hours earlier than
10 nmol/L testosterone. In separate settings of experi-
ments, cycloheximide (10 lg/mL), a combination of T
and cycloheximide, or buffer control, respectively, was
used. In other experiments, 17b-estradiol (10 nmol/L)
was used in combination with T. To determine a role of
caspases in 10 nmol/L T-induced cell death, HK-2 cells
were preincubated for 30 minutes with 50 lmol/L cas-
pase inhibitors. Caspase-8 inhibitor II (Z-IEDT-FMK),
caspase-9 inhibitor I (Z-LEHD-FMK), and caspase-3 in-
hibitor I (DEVD-CHO) were used.
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Cell viability
Experiments were carried out by adding T at scalar
doses to 105 cells cultured in 12-well plates. Nontreated
cells were used as control. After 24 and 48 hours of in-
cubation, cells were counted using a NeuBauer chamber
(Corning Costar Co., Cambridge, MA, USA). Cell viabil-
ity was assessed by Trypan blue. For each treatment group
the number of adherent cells at t = 0 served as baseline
value (100%), and was used to express the percentage of
adherent cells.
Lactate dehydrogenase release
The amount of lactate dehydrogenase (LDH) activity
released into the medium was measured to assess the
leakage of normal components of the cytoplasm into
the medium. For LDH assay, supernatant aliquots were
transferred to the corresponding wells of a 96-well plate.
Then 100 lL of substrate containing L-(+)-lactic acid,
b-NAD, p-iodonitrotetrazolium violet, phenazine
methosulfate, and Tris buffer were added at each well
and incubated at 37◦C until reaching a plateau. The
absorbance was calculated at 540 nm using a scanning
multiwell spectrophotometer.
Annexin V-FITC/propidium iodide (PI) staining
In multiple experiments, HK-2 cells were stained with
annexin V/propidium iodide and observed under a flu-
orescence microscope. The assay is based on the ability
of annexin V (green fluorescence) to bind to the phos-
phatidylserine exposed on the surface of cells undergoing
apoptosis and the capacity of propidium iodide (red fluo-
rescence) to enter cells that have lost their membrane in-
tegrity. HK-2 cells were grown on chamber slides, washed
with Dulbecco’s phosphate buffer solution (DPBS), and
incubated in the dark for 5 minutes at room temperature
with 200 lL of 1× binding buffer, 1 lL of FITC-labeled re-
combinant annexin V, and 1 lL of propidium iodide. Cells
were observed and counted (300 cells for each condition
and experiment) under a fluorescence microscope using
dual filter set for FITC and rhodamine. Cells that lost
membrane integrity showed red staining throughout the
nucleus and a halo of green staining on the cell surface. To
evaluate apoptotic phenomena, we considered the per-
centage of cells annexin V–positive/propidium iodide–
negative.
Terminal deoxynucleotidyl transferase-mediated
uridine triphosphate nick end-labeling (TUNEL)
HK-2 cells grown on chamber slides to subcon-
fluence were incubated for 48 hours with or with-
out T (10 nmol/L). After a five-minute incubation in
2% paraformaldehyde, cells were fixed in 2:1 vol/vol
ethanol:acetic acid at room temperature for 10 min-
utes. After three washes with phosphate-buffered saline
(PBS), cells were incubated with 100 U/mL TdT, 0.5
lg/mL biotynilated uridine triphosphate in 140 mmol/L
potassium cacodylate, 125 mmol/L Tris-HCl, 2.5 mmol/L
cobalt chloride, pH 6.6, for 1 hour at 37◦C in a humidi-
fied chamber. After stopping the reaction by transferring
the slides to tris-borate (TB) buffer (300 mmol/L sodium
chloride, 30 mmol/L sodium citrate) and washing in PBS,
cells were incubated for 30 minutes at room tempera-
ture with extra-avidin-peroxidase diluted 1:20 in PBS,
and then incubated with the peroxidase-substrate solu-
tion (0.04% 3,3-diaminobenzidine in 50 mmol/L Tris-HCl
buffer containing 0.03% hydrogen peroxide) for 5 min-
utes. After rinsing with PBS, sections were counterstained
with hematoxylin and examined by light microscopy.
Cell immunofluorescence and immunostaining
The expression of Fas, FasL, FADD, and p17 fragment
of the active caspase-3 protein were initially documented
by immunofluorescence. HK-2 cells were grown on cham-
ber slides to subconfluence and incubated for 48 hours in
the presence or absence of 10 nmol/L T. Cells were then
washed with cold PBS and fixed in cold methanol for
5 minutes. After a 30-minute incubation with anti-FAS
(polyclonal Ab 1:40 in PBS), anti-FASL (polyclonal Ab
1:40 in PBS), anti-FADD (monoclonal Ab, 20 mg/mL),
or antiactive caspase (polyclonal Ab, 20 mg/mL) antibod-
ies at room temperature, cells were washed extensively
with PBS and exposed to biotinylated conjugated sec-
ondary antibody for 30 minutes. After being washed, cells
were incubated with FITC-streptavidin for 30 minutes.
Slides were observed under a fluorescence microscope.
The expression of cleaved PARP-1, Bax, and Bcl-2 pro-
teins was documented by immunostaining. Both attached
and floating cells were harvested by trypsin and incubated
on poly-L-lysine coated glass slides for 40 minutes at 4◦C.
Then, the spots were air-dried and fixed in cold acetone
for 30 seconds and stored at −20◦C until the immunode-
termination of cleaved PARP-1, Bax, and Bcl-2. After
rehydration in PBS, spots were incubated with the an-
tihuman cleaved PARP-1 polyclonal antibody (dilution
1 lg/mL in PBS), anti-Bax polyclonal antibody (1:200
in PBS), and anti-Bcl-2 monoclonal antibody (1:200 in
PBS) at room temperature. The second and third steps
were performed using the improved biotin-streptavidin-
amplified detection system. Briefly, cells were incubated
with the secondary antibody (biotinylated IgG; 1:100 in
PBS) for 20 minutes. After several washes with PBS,
cells were incubated with the concentrated enzyme label
(biotin-streptavidin-peroxidase) for 20 minutes at room
temperature. Peroxidase was developed with 0.04% 3,3-
diaminobenzidine in 50 mmol/L Tris-HCl buffer con-
taining 0.03% hydrogen peroxide for 15 minutes. Af-
ter rinsing with PBS, slides were counterstained with
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hematoxylin, coverslipped with Eukitt, and examined by
light microscopy.
Image analysis
Image analysis was performed by the Leica Q500 MC
Image Analysis System (Leica, Cambridge, UK). For
each sample 300 cells were randomly analyzed and the
optical density of the signals was quantitated by a PC com-
puter. The video image was generated by a CCD Camera
(Leica, Cambridge, UK) connected through a frame grab-
ber to a PC computer. Single images were digitized for
image analysis at 256 gray levels. Imported data were ana-
lyzed quantitatively by Q500MC Software-Qwin (Leica).
The single cells were randomly selected by the operators
using the cursor, and then positive areas automatically
estimated. Constant optical threshold and filter combi-
nation were used [19, 20].
Western blot analysis
The cell layers (including the floating cells) were
washed twice with cold DPBS and cold lysis buffer
[20 mmol/L HEPES, 150 mmol/L NaCl, 10% (v/v) glyc-
erol, 0.5% (v/v) NP-40, 1 mmol/L EDTA, 2.5 mmol/L
DTT, 10 lg/L aprotinin, leupeptin, pepstatin A, 1mmol/L
PMSF, and Na3VO4]. Cells lysates were incubated for
1 hour at 4◦C, and the insoluble material was re-
moved by centrifugation at 13,000 rpm for 20 minutes
at 4◦C. Protein concentration was determined by using
the Coomassie protein reagent. Protein (30 or 50 lg)
was loaded on 10% to 15% SDS-PAGE under reduc-
ing or nonreducing conditions after being heated for
3 minutes at 100◦C. The proteins were electrotrans-
ferred to a nitrocellulose membrane. Blots were blocked
for 1 hour at room temperature in PBS 5% milk. The
membrane was incubated overnight at 4◦C with antihu-
man BAX, antihuman BCL-2, antihuman Fas, antihuman
FasL, anti-FADD, antiactive caspase-3, (p17 fragment),
anti-cleaved PARP-1 (p85 fragment), followed by three
washes (total 30 minutes) with PBS 0.05% (v/v) Tween
20. The membranes were incubated with horseradish
peroxidase-conjugated secondary antibodies for 1 hour
at room temperature. Immunoblots were developed with
the ECL Western blotting detection system.
Statistical analysis
Statistical analysis was performed with the InStat soft-
ware package version 2.01 (Graph Pad, San Diego, CA,
USA). The one-way analysis of variance (ANOVA) and
the Tukey-Kramer multiple comparison test were used to
test the significance of differences. Results are expressed
as mean ± SD and are the expression of at least three
experiments, with two wells for each experiment. Differ-
ences were considered statistically significant if P < 0.05.
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Fig. 1. Effects of increasing doses of testosterone (T) on proximal hu-
man tubule cell line (HK-2) (A) and proximal tubular epithelial cells
(PTEC) (B) viability at 24 () and 48 () hours. Cell viability was as-
sessed by counting the number of adherent and floating cells. For each
treatment group the number of cells at t = 0 served as baseline value
100% and was used to express the percentage of living cells. ∗P < 0.001
vs. control (C); #P < 0.05 vs. C. Effects of 10 nmol/L and 1 lmol/L of
T on HK-2 (C) and PTECs (D). LDH release at 48 hours. Results are
expressed as mean ± SD and are representative of 3 separate experi-
ments. Each one was carried out in triplicate. The differences were not
statistically significant.
RESULTS
Cell viability
During the course of the experiments, the majority of
cells remained viable and attached to culture dishes in
control cultures over a 48-hour period (88 ± 6.5% of
HK-2 cells and 93 ± 6.4% of primary PTECs were viable,
respectively, at 48 hours) (Fig. 1). To examine the apop-
totic effects of androgens, cells were treated with different
concentrations of T (0.1 nmol to 1 lmol/L). When T was
used at the lowest physiologic doses (0.1 to 10 nmol/L),
83 ± 8% and 90.5 ± 9% of HK-2 cells and PTECs, re-
spectively, were viable at 24 hours (P > 0.05 vs. untreated
cells). These percentages did not significantly change at
48 hours (80 ± 2% and 80 ± 11%, respectively, for HK-
2 cells and PTECs) (Fig. 1A and B). With 1 lmol/L T
(a concentration which is greater than that commonly
found circulating in vivo in man) [21], cell viability was
significantly decreased at 48 hours (62 ± 5% of HK-2
cells; 76 ± 5% of PTECs viable).
There were no significant changes in LDH release
(Fig. 1C and D) in untreated cells at 48 hours. Similarly,
the addition of T did not cause cell injury, as represented
by LDH release.
Effects of T on apoptosis in renal tubular cells
Cultured HK-2 cells and primary PTECs were in-
cubated with different concentrations of T for 24 and
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Fig. 2. Apoptosis in proximal human tubule cell line (HK-2) cultures
stained with annexin V (green fluorescence) and propidium iodide (red
fluorescence). Control HK-2 (A), HK-2 treated with 10 nmol/L testos-
terone (T) for 48 hours (×400) (B). DNA strand breaks as assessed by
terminal deoxynucleotidyl transferase-mediated uridine triphosphate
nick end-labeling (TUNEL) staining of HK-2. Cells were exposed or
not exposed to 10 nmol/L T for 48 hours and subjected to TUNEL
staining. Control HK-2 (C), HK-2 exposed to 10 nmol/L T (×400) (D).
48 hours in multiple experiments and subjected to
apoptosis assay(s). Treatment with T induced several
apoptotic features both in HK-2 cells (Fig. 2A-D) and
PTECs. Features of the T-treated cells stained by TUNEL
observed by light microscopy included rounding and
detachment of the cells with fragmentation and shrink-
ing of nuclei. Apoptotic cells showed chromatin
condensation and fragmentation of nuclear material. The
treatment with T also increased the percentage of annexin
V/propidium iodide–positive cells, as shown by halo of
green staining on cell surface (Fig. 2B). During the course
of these experiments, only 3.60 ± 1.93% of the untreated
HK-2 cells was annexin V–positive at 24 hours (P = NS
vs. t = 0), and this percentage increased slightly (9.7 ±
3.01%) at 48 hours. T induced a progressive rise in apop-
totic HK-2 cells (Fig. 3A), with a 2- to 3-fold increase be-
ing observed at 24 hours (12.3 ± 2.5% and 14.6 ± 2.46%
for T 0.1 to 10 nmol/L, P < 0.05 to 0.01 vs. control). Anal-
ogous findings were observed at 48 hours (Fig. 3A). A
similar trend was observed when cells were grown for
48 hours at different concentrations of T in 0.5%
charcoal-stripped FBS (data not shown). For both
T 10 nmol/L and 1 lmol/L the apoptotic index was signif-
icantly higher than in experiments performed at 24 hours
(P < 0.05 to 0.01).
Similar proapoptotic effects of T were obtained in pri-
mary PTECs (Fig. 3B). At 24 hours, 4.3 ± 2% of the
untreated cells was annexin V–positive, and this percent-
age rose to 10.7 ± 2.4% at 48 hours (P = NS vs. t =
24 hours). When primary PTECs were incubated with
scalar doses of T, we observed a 3-fold increase in the
apoptotic index at 24 hours (13.3 ± 2.3% and 12 ± 1%
for 1 to 10 nmol/L T; P < 0.05 vs. C), which rose further
at 48 hours (18 ± 1.8% and 28.5 ± 6.6% for T 1 nmol/L
and 1 lmol/L, respectively; P < 0.05 to 0.001). Similar to
what was observed with the immortalized line, the apop-
totic index at 48 hours was significantly higher than in
experiments performed at 24 hours (P < 0.05 to 0.01).
Cycloheximide strongly potentiated the apoptotic ef-
fect induced by T. Apoptotic cell death involved ap-
proximately 15% of HK-2 cells after 48 hours, and this
figure raised to 40% when cycloheximide was added to T
(Fig. 4).
Proapoptotic effects of T were abolished by the admin-
istration of the androgen-receptor antagonist flutamide
(100 nmol/L). Only 10.8 ± 4.2% (in HK-2 cells) or 7 ±
1% (in PTECs) of flutamide + T treated cells showed
apoptotic features at 48 hours (P < 0.01 to 0.001 vs. T,
and P = NS vs. C) (Fig. 5A and B).
To examine whether these effects were specific to an-
drogens, in a separate setting of experiments, cells were
treated with 17b-estradiol (10 nmol). Estradiol, per se,
had no effects on apoptosis, but the coincubation of T +
estradiol prevented the increase in the apoptosis induced
by T both in HK-2 cells (Fig. 6A) and PTECs (Fig. 6B-E).
Effect of T on Fas, FasL, and FADD proteins
As a following step, we studied the expression of pos-
sible apoptosis-inducing proteins in HK-2 cells in order
to individuate the underlying apoptotic pathway(s). Be-
cause of the evidence of the Fas-FasL system in prox-
imal tubule cells [1], we first looked at the expression
of Fas, FasL, and FADD induced by T treatment. Fas, a
45-kD member of the tumor necrosis factor (TNF) recep-
tor superfamily, binds to its cognate ligand, FasL. Liga-
tion of Fas causes rapid death-inducing FADD signaling
complex formation. The protein is recruited to the re-
ceptor’s DD and primes the apoptotic pathway [1]. HK-2
cells were analyzed by immunofluorescence, SDS-PAGE,
and Western blotting with antibodies to Fas, FasL (a 37-
kD protein), and FADD protein (24-kD). The basal low
amount of FasL in the cell surface is consistent with data
from murine tubular cells [15], as well as other cell types
where most FasL is bound to intracellular membranes
[22]. Our study revealed a clear up-regulation of Fas,
FasL, and FADD in proximal tubule cells within 48 hours
of T treatment (Figs. 7 and 8).
Effect of caspase inhibition
Starting from the above data, we sought to evaluate the
downstream effectors of the Fas-FasL pathway, includ-
ing the caspase family [23]. Two main pathways leading
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Fig. 3. Apoptosis detection by annexin V/propidium iodide. Subconfluent proximal human tubule cell line (HK-2) (A) and proximal tubular
epithelial cells (PTECs) (B) were growth factor– and serum-deprived for 24 and 48 hours in presence of testosterone (T) (0.1 nmol/L to 1 lmol/L).
Cells were stained with annexin V/propidium iodide and examined under fluorescence microscope. Apoptotic cells were expressed as percent of
total cells counted (350 cells for each condition). Data shown as mean ± SD. Each experiment was performed in triplicate. ∗P < 0.05; ∗∗P < 0.01;
∗∗∗P < 0.001 vs. untreated cells (control); #P < 0.05 vs. 10 nmol/L 24 hours; ##P < 0.01 vs. 1 lmol/L 24 hours.
0
10
20
30
40
50
60
%
 A
po
pt
ot
ic 
ce
lls
C CLX T T+CLX
**
*
#
⊥
Fig. 4. Apoptosis detection by annexin V/propidium iodide. Subcon-
fluent proximal human tubule cell line (HK-2) were growth factor– and
serum-deprived for 24 hours in the presence or absence of testosterone
(T) (10 nmol/L) and cycloeximide (10 lg/mL) (CLX). ∗P < 0.05 vs.
control (C); ∗∗P < 0.001 vs. T; #P < 0.001 vs. T; ⊥P < 0.001 vs. CLX.
to apoptosis through caspase activation have been de-
scribed. On one way, the “extrinsic pathway” is activated
by receptors of the TNFR superfamily through mech-
anisms that involve the adapter protein FADD, which
activates the initiator caspase-8. On the other way, the
“intrinsic pathway” is activated by mitochondial proteins
through the action of the initiator caspase-9. Since the
inhibition of caspase functions has been shown to block
the development of programmed cell death [24], we eval-
uated whether T-induced HK-2 cell apoptosis could be
prevented by treatment with different inhibitors. The re-
sults revealed that the change in cellular morphology in-
duced by T at 48 hours were no longer observed after
the addition of Z-IEDT-FMK (caspase-8 inhibitor II),
Z-LEHD-FMK (caspase-9 inhibitor I) and DEVD-CHO
(caspase-3 inhibitor I) to the culture medium. The anti-
apoptotic effects were of similar entity for all inhibitors
(Fig. 9).
T-induced apoptosis is associated with the activation
of caspase-3
Caspase-3 is one of the key executioners of apop-
tosis and is responsible either partially or totally for
the proteolytic cleavage of many key proteins, such as
the nuclear enzyme PARP-1. HK-2 cells incubated for
48 hours with 10 nmol/L T were analyzed by immunofluo-
rescence, SDS-PAGE, and Western blot with a polyclonal
antibody to caspase-3, which detects only the p17 frag-
ment of active caspase-3. Results showed that caspase-3
is activated during T treatment (Figs. 10A and B, 11).
We next checked for the cleavage of PARP-1, an endoge-
nous substrate for caspase-3. During apoptosis, caspase
3 cleaves PARP-1 to yield an 85-kD and a 25-kD frag-
ment. We examined PARP-1 expression by immunostain-
ing and Western blot (Fig. 11). Cleavage into an 85-kD
terminal breakdown product was detectable on Western
blots in T-treated cells, confirming that caspase-3 was act-
ing on cellular substrates.
Effects of T on Bax and Bcl-2
Because T-induced apoptosis is inhibited by caspase-9
inhibitor I (Z-IEDT-FMK), we examined the expression
of Bax and Bcl-2. T treatment significantly increased the
expression of Bax protein (P < 0.01 vs. C) (Fig. 12B and
D). The pretreatment with flutamide did not induce this
increase, and the expression of Bax was similar to con-
trol. The expression of Bcl-2 was opposite respect to Bax
(Fig. 12A and C).
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Fig. 5. Apoptosis detection by annexin V/propidium iodide. Subconfluent proximal human tubule cell line HK-2 (A) and proximal tubular epithelial
cells (PTECs) (B) were growth factor– and serum-deprived for 48 hours in the presence of testosterone (T) (10 nmol/L), flutamide (F) (100 nmol/L)
alone, or T plus F (added 4 hours earlier than T). Data are shown as the mean ± SD from three representative experiments, with two wells of the
cells for each treatment. ∗P < 0.01 vs. 10 nmol/L T; ⊥P < 0.001 vs. C; ∗∗P < 0.001 vs. 10 nmol/L T.
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Fig. 6. Apoptosis detection by annexin V/propidium iodide. Subcon-
fluent proximal human tubule cell line (HK-2) (A) and proximal tubular
epithelial cells (PTECs) (B) were growth factor– and serum-deprived
for 48 hours in the presence of T (10 nmol/L), 17b-estradiol (E) (10
nmol/L) alone, or T plus E. Data are shown as the mean ± SD from
three representative experiments, with two wells of the cells for each
treatment. ∗P < 0.001 vs. control (C); #P < 0.001 vs. E; ⊥P < 0.01 vs.
E. Apoptosis in primary PTEC cultures stained with annexin V (green
fluorescence) and propidium iodide (red fluorescence): Control PTECs
(C); PTECs treated with 10 nmol/L for 48 hours (D); PTECs exposed
to T and E (10 nmol/L) for 48 hours (×400) (E).
DISCUSSION
The present study shows that androgens promote apop-
totic damage in human proximal tubule cells, as evaluated
by multiple apoptosis-associated determinations, includ-
ing morphologic observation of TUNEL-stained cells,
annexin V binding, and detection of apoptosis-related
proteins. Moreover, these effects are observed at T lev-
els that are in the physiologic range and are blocked
by androgen receptor inhibition and estrogens. These
findings are observed both in immortalized and pri-
mary proximal tubular cells. According to our data, an-
drogens increase the permissiveness of tubular cells to
apoptotic effects by triggering apoptotic pathways involv-
ing Fas up-regulation, FasL expression, and caspase(s)
activation.
When we blocked survival signals with cycloheximide,
apoptosis occurred rapidly. We observed that combined
treatment with androgens and cycloheximide generated
additive apoptotic effects compared to T alone, suggest-
ing a correlation between the inhibition of protein syn-
thesis and T-mediated apoptosis. Both conditions induced
the typical morphologic findings and the cell surface pro-
gram characteristic for apoptosis.
Fas has been recognized in several nonlymphoid or-
gans, including the kidney [1, 14, 24]. In contrast, FasL, a
40-kD type II membrane protein, is expressed in a more
restricted number of tissues, where it can promote apop-
tosis through the activation of Fas receptors [1]. The reg-
ulation of FasL-induced apoptosis is complex, and some
cell types express FasL but are unable to promote apop-
tosis [25]. Fas is expressed in renal tubular epithelial
cells, but the role of the Fas-FasL system on apoptosis
has been demonstrated only recently [1]. It has been
previously observed that Fas/FasL-induced apoptosis
promotes parenchymal cell damage in models of acute
renal failure and glomerular injury [1]. According to our
data, human proximal tubular cells are activated by T
and show an up-regulated expression of Fas/FasL, which
can contribute to their increased susceptibility to FasL-
mediated apoptosis. In keeping with these findings, we
found that the effector caspase-3 was activated by T, and
that a hallmark caspase substrate, PARP-1, was cleaved.
As an additional finding, our data suggest that T works
primarily through a FADD- and caspase-8–dependent
pathway. However, the involvement of caspase-9 in the
degeneration process was somewhat unexpected. On
one hand, it is possible that caspase inhibitors studied
here are not equipotent, but that their effect may change
according to individual substrate and inhibition kinetics.
On the other hand, apoptotic changes were associated
with an increased expression of Bax together with a de-
crease in the antiapoptotic protein Bcl-2 in T-treated cells,
therefore suggesting an interaction between the extrin-
sic and intrinsic pathway. Caspase-8 may either directly
activate procaspase-3 or cleave the proapoptotic pro-
tein Bid, which then subsequently induces cytochrome
c release [27]. Nevertheless, the final result of either
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Fig. 7. Testosterone (T) treatment induces
Fas (D), FasL (E), and Fas-associating death
domain containing protein (FADD) (F), with
respect to untreated cells (A, B, and C for Fas,
FasL, and FADD, respectively) (×400).
43 kD
Fas
37 kD
Fas-L
24 kD
FADD
C T
Fig. 8. Testosterone (T)-induced apoptosis is associated with up-
regulation of Fas, Fas-L, and Fas-associating death domain containing
protein (FADD). Cells incubated for 48 hours with 10 nmol/L of T were
subjected to Western analysis with the various antibodies as shown. The
results are representative of 3 different experiments.
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Fig. 9. Effects of the caspase inhibitor 3 (DEVD-CHO), caspase in-
hibitor 8 (Z-IEDT-FMK), and caspase inhibitor 9 (Z-LEHD-FMK) (50
lmol/L) on 10 nmol/L testosterone (T)-induced apoptosis at 48 hours.
Apoptotic cells were assessed by annexin V/propidium iodide and the
values are the mean ± SD of 3 different experiments. ∗P < 0.01 vs. 10
nmol/L T.
pathway is caspase activation, resulting in the biochem-
ical and morphologic changes associated with the apop-
totic phenotype.
The mechanisms responsible for gender differences in
progression rates of chronic diseases are not yet clear and
continue to be the object of investigation. Changes ob-
Fig. 10. Expression of p17 fragment active caspase-3 by immunoflu-
orescence (upper panel) and cleaved poly(ADP-ribose) polymerase
(PARP-1) by immunocytochemistry (lower panel) in control (A, C)
and testosterone (T)-treated cells (B, D). T activates caspase-3 and its
activation is documented by PARP-1 cleavage (×400).
P17 kD fragment
Active caspase-3 
85 kD
PARP-1
C T
Fig. 11. Testosterone (T)-induced apoptosis is associated with acti-
vation of caspase-3 and cleavage of poly(ADP-ribose) polymerase
(PARP-1). Cells incubated for 48 hours with 10 nmol/L of T were sub-
jected to Western analysis with the various antibodies as shown. The
caspase-3 antibody detects only the p17 fragment active; the PARP
antibody detects only the cleaved 85-kD fragment. The results are rep-
resentative of 3 different experiments.
served in tubule cells under serum-free culture in vitro
appear very similar to the apoptotic damage occurring
in vivo in the tubuli subjected to ischemia or chronic re-
nal disease [28–30]. The androgen-promoted apoptotic
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Fig. 12. Expression of antiapoptotic Bcl-2 (A) and proapoptotic Bax (B) proteins were evaluated by immunocytochemistry and image analysis.
Cells subjected to 10 nmol/L testosterone (T) for 48 hours showed alteration in Bcl-2 and Bax proteins with respect to control (C) cells and cells
pretreated with flutamide (F). Data are expressed as mean ± SD of 4 separate experiments. ∗P < 0.001 vs. C. Expression of antiapoptotic Bcl-2 (C)
and proapoptotic Bax (D) proteins evaluated by Western blot. Results are representative of 3 different experiments.
damage might interact with the apoptotic pathway al-
ready activated in several chronic kidney diseases. It has
been previously shown that renal FasL may potentially
regulate the immune response and promote parenchymal
cell death in several experimental models of chronic kid-
ney disease [22]. The Bax/Bcl-2 ratio (through caspase-3
activation) has been shown to modulate renal cell apop-
tosis associated with the progressive renal damage in
immune-mediated experimental glomerulonephritis [26],
in the subtotal nephrectomy model of chronic renal scar-
ring [29], in adult polycystic kidney disease (APKD) [30],
and in experimental obstructive nephropathy [31]. There-
fore, the pathways to cell death, which are primed by an-
drogens, as shown by the present study, are shared by sev-
eral conditions leading to the loss of renal cells in chronic
disease.
CONCLUSION
Physiologic T levels cause intracellular events, allow-
ing Fas sensitization and leading to activation of caspase-
dependent apoptotic pathway in human renal tubule cells.
This is consistent with a role for T in promoting renal in-
jury in men.
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